18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
2019-11-29
/
部门规范性文件
中国
现行有效
/
国家药品评价中心
为落实药品上市许可持有人药品安全主体责任,规范持有人药物警戒年度报告撰写工作,按照国家药品监督管理局要求,国家药品不良反应监测中心组织制定了《药品上市许可持有人药物警戒年度报告撰写指南(试行)》,现予发布。
附件:
摩熵医药2025-01-08
摩熵医药2024-12-17
Pharma CMC2024-10-15
摩熵医药(原药融云)2024-08-21
数屿医械2024-06-24
数屿医械2024-06-13
数屿医械2024-05-30
摩熵医药(原药融云)2024-05-27
药事纵横2024-02-28
药通社2023-12-26
2025-01-16
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-14
2025-01-14
2025-01-14
2025-01-13
2025-01-13
2025-01-13
2025-01-13
2025-01-13
2024-12-16
2024-12-16
2024-12-16
2024-12-16
2024-12-16
2024-12-13
2024-12-04
2024-12-04
2024-12-04
2024-12-04
2024-12-04
2024-11-08
2024-10-25
2024-06-24
2024-06-07
2025-01-16
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-15
2025-01-14
2025-01-14
2025-01-14
2025-01-13
2025-01-13
2025-01-13
2025-01-13
2025-01-13